• About Us
    • Company Overview
    • Our History
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Our Advisors
  • Therapeutic Areas
    • COVID-19 and CVD
    • Acute Myocarditis
    • Heart Failure
  • Research
    • R&D Partners
    • Our Science
    • Resources
  • Pipeline
  • CardiolRX™
  • Investors
    • Events & Presentations
    • Press Releases
    • Analyst Coverage
    • Stock Information
    • Filings & Financials
    • Corporate Governance
    • Contact Us
  • Events & Presentations
  • Press Releases
  • Analyst Coverage
  • Stock Information
  • Filings & Financials
  • Corporate Governance
  • Investor Relations Contact
Investors

Board Members & Committees

  • Chair
  • Member
Director Audit Compensation Governance

Guillermo Torre-Amione

Jennifer M. Chao

Peter Pekos

Michael J. Willner

Colin Stott

Governance Documents

Name View Document
Audit Committee Charter Download
Board of Directors Mandate Download
Code of Business Conduct and Ethics Download
Corporate Governance and Compensation Committee Mandate Download
Insider Trading Policy Download
Whistleblower Policy Download
Confidentiality and Disclosure Policy Download
Nasdaq Statement of Governance Differences Download

Corporate Documents

Name View Document
Articles of Incorporation Download
Articles of Amendment (August 29, 2018) Download
Articles of Amendment (February 13, 2017) Download
By-Law No. 1. Download
Majority Voting Policy Download
  • About Us
  • Therapeutic Areas
  • Research
  • Pipeline
  • CardiolRX™
  • Investors
  • Contact

TSX:CRDL NASDAQ:CRDL

Sign up to receive the latest news from Cardiol Therapeutics

© 2022 Cardiol Therapeutics Inc. All rights reserved.      Terms of Use      Privacy Policy